Odyssean »

WesBan shares owned by Odyssean

Quarter-by-quarter ownership of WesBan (WSBC) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in WesBan

Tip: Access up to 7 years of quarterly data

All positions including WesBan held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in WesBan by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $599k 15k 39.03

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding WesBan

BlackRock
Vanguard Portfolio Management
Dimensional Fund Advisors
Vanguard Capital Management
Nomura Asset Management International
State Street Corporation
Goldman Sachs Group
Geode Capital Management
Hood River Capital Management
Wellington Management Company
Earnest Partners
Bank of America Corporation
Wesbanco Trust And Investments
Jpmorgan Chase & Co
Verition Fund Management

View all funds holding WesBan